RAG1

RAG1
National Center for Biotechnology Information, U.S. National Library of Medicine · Public domain · source
Name	RAG1
Other names	Recombination-activating protein 1
Uniprot	P15924
Organism	Human

RAG1

RAG1 is a recombination-activating protein essential for adaptive immunity in jawed vertebrates. It operates with RAG2 to initiate V(D)J recombination that generates diverse antigen receptors in B lymphocytes and T lymphocytes, and has been studied across immunology, molecular biology, and clinical genetics. Its discovery intersected with research from laboratories associated with the Howard Hughes Medical Institute, the National Institutes of Health, and institutions led by scientists such as Susumu Tonegawa and Frederick Alt.

Introduction

RAG1 was identified in screens linking lymphocyte development defects to chromosomal loci studied at Massachusetts Institute of Technology, Harvard Medical School, and the National Institutes of Health. Early characterization connected RAG1 activity to models pioneered by researchers at Cold Spring Harbor Laboratory and to seminal concepts developed by investigators at Imperial College London and University of Cambridge. The protein is central to processes described in foundational texts associated with Rockefeller University and techniques refined at Stanford University and University of California, San Francisco.

Structure and Biochemistry

RAG1 encodes a protein of approximately 1040 amino acids in mammals, with a catalytically active core comprising residues that coordinate divalent metal ions and DNA cleavage. Structural studies used methods developed at European Molecular Biology Laboratory and facilities at Argonne National Laboratory and Oak Ridge National Laboratory for crystallography and cryo-electron microscopy. The catalytic core contains a DDE (Asp-Asp-Glu)-like motif analogous to motifs characterized in transposases studied at Max Planck Institute for Developmental Biology and enzymes researched in the laboratories of Nobel laureate Thomas Steitz and Ada Yonath. RAG1 forms a complex with RAG2, and the heteromeric assembly engages DNA containing recombination signal sequences (RSS). Biochemical assays performed at Salk Institute and Johns Hopkins University defined metal dependence (Mg2+, Mn2+) and strand transfer chemistry reminiscent of transposition reactions elucidated at Cold Spring Harbor Laboratory.

Function in V(D)J Recombination

RAG1 mediates site-specific cleavage at RSS adjacent to variable (V), diversity (D), and joining (J) gene segments in loci such as the immunoglobulin heavy chain locus and T cell receptor loci studied at Memorial Sloan Kettering Cancer Center and Mayo Clinic. The RAG1–RAG2 complex introduces a single-strand nick and a hairpin on coding ends, initiating non-homologous end joining pathways characterized by researchers at Yale University and University of Pennsylvania. The mechanism parallels transposase action described by investigators at University of Oxford and University of Edinburgh, and the concerted cleavage and joining steps interact with DNA repair factors identified in studies at Children's Hospital of Philadelphia and University of California, San Diego. Functional assays in model organisms from Massachusetts General Hospital and University of Washington linked RAG1 activity to antigen receptor repertoire diversity investigated by groups at Institut Pasteur and Weill Cornell Medicine.

Regulation and Expression

RAG1 expression is tightly regulated during lymphocyte development in tissues such as bone marrow and thymus examined at Mayo Clinic, Johns Hopkins University, and Fred Hutchinson Cancer Center. Transcriptional control involves promoters, enhancers, and transcription factors characterized at Columbia University and Massachusetts Institute of Technology. Post-translational modifications including ubiquitination and phosphorylation were described in studies from National Cancer Institute and Scripps Research, while chromatin accessibility influences RAG1 targeting in work from University of Chicago and Rockefeller University. Developmental stages, such as pro-B, pre-B, and double-positive thymocytes, correlate with RAG1 expression patterns reported by groups at National Institute of Allergy and Infectious Diseases and University of Michigan.

Clinical Significance and Genetic Disorders

Mutations in RAG1 are implicated in a spectrum of immunodeficiencies and lymphocyte development disorders studied clinically at Great Ormond Street Hospital, Boston Children's Hospital, and Seattle Children's Hospital. Severe combined immunodeficiency (SCID)-phenotypes, Omenn syndrome, and hypomorphic mutations producing combined immunodeficiency with granulomas and autoimmunity have been described in cohorts from Mayo Clinic and Institut National de la Santé et de la Recherche Médicale. Genetic screening panels developed at Quest Diagnostics and clinical trials overseen by investigators at NIH Clinical Center evaluate hematopoietic stem cell transplantation and gene therapy strategies refined in programs at St. Jude Children's Research Hospital and University College London. Functional assays for variant interpretation draw on standards from American College of Medical Genetics and Genomics and variant databases curated by groups at Broad Institute.

Evolutionary Conservation and Comparative Biology

RAG1 shows conservation among jawed vertebrates and is absent in jawless vertebrates and invertebrates, a distribution documented by comparative genomics teams at European Bioinformatics Institute and Wellcome Sanger Institute. Phylogenetic analyses linking RAG1 to transposase ancestors were advanced by researchers at Max Planck Institute for Evolutionary Anthropology and University of California, Berkeley, and paleogenomic contexts were explored by groups at Harvard University and University of Toronto. Studies in model species including zebrafish, mouse, and chicken conducted at Cold Spring Harbor Laboratory and Roslin Institute illuminated functional conservation and divergence, while horizontal transfer hypotheses were debated in literature associated with Princeton University and University of Basel.

Category:Proteins Category:Immune system proteins